en.Wedoany.com Reported - Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) announced the completion of its acquisition of all partnership interests in Agribusiness Holdings Limited Partnership and its subsidiary, Bridgewell Agribusiness LLC. The total consideration is based on a base purchase price of $40 million, with the adjusted closing purchase price approximately $13.66 million. Vireo issued an unsecured subordinated convertible note to the seller, which will convert into a total of approximately 22,036,528 shares of Vireo's subordinate voting shares two years after closing, at a deemed price of $0.62 per share.
Bridgewell is a supplier of organic and non-GMO food and agricultural products to manufacturers, acting as an intermediary between agricultural producers and food manufacturers. Vireo CEO John Mazarakis stated that this transaction represents a significant step in the evolution of the company's supply chain and procurement strategy, and that Bridgewell's sourcing expertise and scalable infrastructure will enhance the company's ancillary cannabis business segment. Bridgewell CEO Patrick McCauley noted that joining Vireo will help expand the platform and seek new growth opportunities.
In terms of dispensary operations, Vireo entered into an asset purchase agreement with M3 Wellness, LLC on June 5, 2026, to acquire a dispensary located in Hawthorne, Nevada, for a total consideration of $500,000. The payment includes $290,000 in cash and 416,667 shares of Vireo's subordinate voting shares. If specific EBITDA benchmarks are met by December 31, 2029, Vireo is required to pay additional performance-based consideration. The transaction is subject to regulatory approval from the Nevada Cannabis Compliance Board.
Vireo is also continuing to advance a previously signed definitive agreement dated November 3, 2025, to acquire an indirect 49% equity interest in Chesapeake Integrated Health Institute, LLC and Maryland Alternative Relief, LLC from existing members of HA-MD, LLC, for a total consideration of $1.55 million. The payment includes $400,000 in cash, a $400,000 promissory note, and 1,111,110 shares of Vireo's subordinate voting shares, at a deemed issuance price of $0.675 per share. The transaction has received regulatory approval from the Maryland Cannabis Administration.
Founded in 2014, Vireo is a medical cannabis company that builds its business platform through local market operations and a national portfolio.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
